Development of a Polo-like Kinase-1 Polo-Box Domain Inhibitor as a Tumor Growth Suppressor in Mice Models | Journal of Medicinal Chemistry
Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4+ T cells ex vivo | Science Advances
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential | Journal of Medicinal Chemistry
Synthesis and evaluation of small molecule-based derivatives as inhibitors of polo-box domain of polo-like kinase-1 | Journal of Analytical Science and Technology | Full Text
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
Cancers | Free Full-Text | The CINs of Polo-Like Kinase 1 in Cancer
PLK Signaling Pathway - Creative Diagnostics
Recent Progress in Development of Polo-Like Kinase 1 Inhibitors: Efforts So Far
Peptidomimetics Targeting the Polo-box Domain of Polo-like Kinase 1 | Journal of Emerging Investigators
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology
Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis
PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar
Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization | PNAS